| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/14/2002 | DE10103565A1 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 08/14/2002 | CN1364171A Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364089A Chronic myeloid leukemia (CML) therapy |
| 08/14/2002 | CN1364087A Methods of treatment and drug screening methods |
| 08/14/2002 | CN1364086A Use of interleukin-18 inhibitors to inhibitor tumor metastasis |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364084A Method of inducing cancer cell death and tumor regression |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1363681A Activated lymphocyte from umbilical cord blood, preparations containing it as main content and method therefor |
| 08/14/2002 | CN1363394A Process for preparing nano particles of hydroxycamptothecine polylactate |
| 08/14/2002 | CN1363372A Chinese medicine for treating cancer |
| 08/14/2002 | CN1363340A Nano medicine 'Compound Jew's Ear' and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/14/2002 | CN1363277A Freeze-dried powder injection and its preparing process |
| 08/14/2002 | CN1089007C Immunotherapeutic method of treating cancerous diseases by administration of gamma glubulins |
| 08/14/2002 | CA2371487A1 Tricyclic sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/13/2002 | US6433451 Method and electric motor with rotational stator |
| 08/13/2002 | US6433187 Certain polycyclic compounds useful as tubulin-binding agents |
| 08/13/2002 | US6433180 Carboxylic acids for synthesis of taxane derivatives |
| 08/13/2002 | US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof |
| 08/13/2002 | US6433150 Antitumor agents |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433148 Immunoglobulin antibodies with amino acid sequences |
| 08/13/2002 | US6433143 Tie-2 ligands |
| 08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 08/13/2002 | US6433000 Aromatic sulfamate derivatives as sulfatase inhibitors; estrogen receptor blockers; breast cancer treatment |
| 08/13/2002 | US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
| 08/13/2002 | US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors |
| 08/13/2002 | US6432982 Benzothiophenes, and formulations and methods using same |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432971 Method of prevention of prostatic carcinoma with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones |
| 08/13/2002 | US6432967 Enema and enterically-coated oral dosage forms of azathioprine |
| 08/13/2002 | US6432959 Antitumor agents |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432941 Vanadium compounds for treating cancer |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432928 Complexes and their compositions |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432917 Anticancer agents |
| 08/13/2002 | US6432703 Isolated polynucleotide sequences |
| 08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
| 08/13/2002 | US6432667 Polynucleotide encoding TIE-2 ligand-4 |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432456 Contains as an effective component a water-soluble component of capsicum annuum l.var.grossumn which is a solanacede plant. |
| 08/13/2002 | US6432452 Topical administering a 20-acetyl-ingenol-3-angelate obtained from plant extracts having preferential cytolysis for cancer cells; metallothionein gene promotors having chemical and heat resistance |
| 08/13/2002 | US6432409 Hybrid peptides modulate the immune response |
| 08/13/2002 | CA2212357C 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them |
| 08/13/2002 | CA2122604C Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/12/2002 | WO2001034196A2 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2398832A1 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2370236A1 Method for inhibiting retinoid skin damage |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061128A2 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061109A2 Yeast strains autonomously producing steroids |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061090A2 Prokaryotically produced antibodies and uses thereof |
| 08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002061033A2 Transfection of human embryonic stem cells |
| 08/08/2002 | WO2002060972A2 Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof |
| 08/08/2002 | WO2002060955A2 Modified antibodies and methods of use |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060927A1 Protein kinase signalling |
| 08/08/2002 | WO2002060911A2 C-glucosyl ether lipids |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060887A2 Synthesis of 4h-chromene derivatives |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | WO2002060868A2 Inhibitors of prenyl-protein transferase |
| 08/08/2002 | WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 08/08/2002 | WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | WO2002060483A2 Perylenequinones for use as photosensitizers and sonosensitizers |
| 08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
| 08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060476A2 Tumor vaccine |
| 08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | WO2002060469A1 Anticancer agents |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060460A1 Remedies for cancer |
| 08/08/2002 | WO2002060457A1 Anti-stress agents |